The Anthrax strain, one of the 89 known anthrax strains, originated from the death of a 14-month-old beef cow in Texas in 1981. As this strain is extremely pathogenic, it has become a focus of global public health community.
The Anse strain did not come from Iowa, but was isolated by the Texas Veterinary Medical Diagnostic Laboratory. Its return address was incorrectly identified, leading to misunderstanding among many researchers and creating confusion about the name.
This strain received widespread attention during the 2001 anthrax mailing incident. At the time, seven letters containing the strain were mailed to media outlets and the offices of several U.S. senators, sparking fears of bioterrorism.
The reason why the Ansi strain is highly pathogenic is mainly caused by the two virulence plasmids it carries (pXO1 and pXO2). These plasmids are critical for bacterial survival and immune evasion.
Plasmid pXO2 generates an anti-phagocytic poly-D-glutamic acid capsule, allowing it to effectively evade the host immune system. Another plasmid, pXO1, produces three toxin proteins, further enhancing its pathogenicity.
Research has shown that if any plasmid is deleted, the pathogenicity of the strain will be significantly reduced, and the pXO2 plasmid of the Ans strain seems to give it higher pathogenicity. This series of closed-loop scientific discoveries will undoubtedly contribute to Biomedical research provides a valuable foundation.
Anse strains remain susceptible to most major antibiotics, making them important in research and vaccine development. Among them, ciprofloxacin is the main therapeutic drug, and among the new fluoroquinolone antibiotics, gafroquinfloxacin has shown special effectiveness against this strain.
In terms of vaccine research and development, using attenuated strains to produce safe and effective vaccines is an important direction. The Sterne strain is an attenuated strain that has lost the pXO2 plasmid and is therefore used as one of the main sources of vaccines.
As technology advances, by identifying specific single nucleotide polymorphisms (SNPs), researchers are able to develop tests and diagnostics to track epidemics. These SNPs are highly specific and can effectively distinguish the Ans strain from 88 other anthrax strains.
The stability of the Ans strain results in less genetic variation, thereby reducing the occurrence of false positive results. In addition, its spores can remain dormant for a long time, allowing them to be more precise in research.
This type of technology is not limited to tracking Ans strains, but can also be extended to other bioterrorism identification projects, and may become an important part of public health security in the future.
From the mysterious past of anthrax to today's vaccine and antibiotic research, the Ans strain is undoubtedly an example that continues to attract attention. How will we monitor and prevent and control these pathogenic bacteria in the future to protect human health? What about safety?